Pierre Gosselin, PhD
Vice President, Business Development
Pierre joined Almatica in October 2018 and is responsible for all Business Development activities for brand products within Almatica and more recently also took responsibility for Business Development activities for Alvogen US. Pierre brings 20+ years of international biopharmaceutical industry experience leading or supporting intellectual property transactions including in- and out-licenses, product acquisitions and divestments, research collaborations, authorized generic and co-promotion agreements as well as M&As.
Before joining Almatica, Pierre held the position of Vice President, Corporate Development at REGENXBIO Inc. and had previously been with Shire since 2001 where he held positions with increasing responsibilities within Shire’s Business Development, leading BD activities for Shire Regenerative Medicine and the GI and Behavioural Health business units of Shire Specialty Pharma. Early in his career, Pierre was Scientific Analyst in R&D and Business Development and then Acting Director, Extramural Research at BioChem Pharma, Inc. (Laval, Canada) with responsibility for global University collaborations and licensing.
Pierre holds a B.Sc. and a M.Sc. in microbiology from Laval University (Quebec, Canada) and a Ph.D. in Experimental Medicine from McGill University (Montreal, Canada) and spent four years as a Fogarty Fellow at the National Cancer Institute (NCI/NIH) in Fort Detrick MD.